AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN in Zimbabwe
10 products registered with MCAZ — 10 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DIPTATRIS 10/160/12.5MG TABLET, COATED; ORAL | 2025/12.3.5/6896 | MYLAN LABORATORIES LIMITED | active | 12 Mar 2030 |
| DIPTATRIS 5/160/25 TABLET, COATED; ORAL | 2025/12.3.5/6895 | MYLAN LABORATORIES LIMITED | active | 12 Mar 2030 |
| DIPTATRIS 5/160/12.5 TABLET, COATED; ORAL | 2025/12.3.5/6894 | MYLAN LABORATORIES LIMITED | active | 12 Mar 2030 |
| DIPTATRIS 10/160/25MG TABLET, COATED; ORAL | 2025/12.3.5/6897 | MYLAN LABORATORIES LIMITED | active | 12 Mar 2030 |
| DIPTATRIS 10/320/25MG TABLET, COATED; ORAL | 2025/12.3.5/6898 | MYLAN LABORATORIES LIMITED | active | 5 Mar 2030 |
| TRI-VALSAPRESS 5;160;12.5 TABLET, COATED; ORAL | 2025/12.3.5/7079 | COSPHARM INVESTMENTS PVT LTD | active | 31 Dec 2027 |
| EXFORGE HCT TABLET; ORAL | 2016/12.3.5/5188 | NOVARTIS PHARMA SERVICES AG | active | 31 Dec 2027 |
| TRI-VALSAPRESS 10; 25 ; 320 TABLET, COATED; ORAL | 2025/12.3.5/7081 | COSPHARM INVESTMENTS PVT LTD | active | 31 Dec 2027 |
| EXFORGE HCT TABLET; ORAL | 2016/12.3/5189 | NOVARTIS PHARMA SERVICES AG | active | 31 Dec 2027 |
| TRI-VALSAPRESS 10;12.5;160 TABLET, COATED; ORAL | 2025/12.3.5/7080 | COSPHARM INVESTMENTS PVT LTD | active | 31 Dec 2027 |
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN — MCAZ Registration Details
MCAZ (Zimbabwe) has 10 registered products containing AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN, of which 10 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.